- ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humans
A Study of SGN-B7H4V in Advanced Solid Tumors
Researchers are testing a new medicine called SGN-B7H4V for several advanced cancers, including certain breast, lung, and ovarian cancers. This early-stage study aims to find a safe dose and see what effects it has. It's for adults whose cancer has spread or come back.
France · Spain · Italy - authorisedHuman Pharmacology (Phase I)- First administration to humans
A Phase 1, multicenter, open-label study of REM-422, a MYB mRNA degrader, in patients with recurrent or metastatic, adenoid cystic carcinoma.
This study is testing a new medicine, REM-422, for adults with a type of cancer called adenoid cystic carcinoma (ACC) that has come back or spread. It's an early-stage study to see if the drug is safe and how it works.
France